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ABSTRACT Structures of truncated versions of the inﬂuenza A virus M2 proton channel have been determined recently by
x-ray crystallography in the open conformation of the channel, and by NMR in the closed state. The structures differ in the position
of the bound inhibitors. The x-ray structure shows a single amantadine molecule in the middle of the channel, whereas in the
NMR structure four drug molecules bind at the channel’s outer surface. To study this controversy we applied computational
solvent mapping, a technique developed for the identiﬁcation of the most druggable binding hot spots of proteins. The method
moves molecular probes—small organic molecules containing various functional groups—around the protein surface, ﬁnds
favorable positions using empirical free energy functions, clusters the conformations, and ranks the clusters on the basis of
the average free energy. The results of the mapping show that in both structures the primary hot spot is an internal cavity over-
lapping the amantadine binding site seen in the x-ray structure. However, both structures also have weaker hot spots at the exte-
rior locations that bind rimantadine in the NMR structure, although these sites are partially due to the favorable interactions with
the interfacial region of the lipid bilayer. As conﬁrmed by docking calculations, the open channel binds amantadine at the more
favorable internal site, in good agreement with the x-ray structure. In contrast, the NMR structure is based on a peptide/micelle
construct that is able to accommodate the small molecular probes used for the mapping, but has a too narrow pore for the riman-
tadine to access the internal hot spot, and hence the drug can bind only at the exterior sites.INTRODUCTION
The integral membrane protein M2 of influenza virus forms
pH-gated proton channels in the viral lipid envelope. The
low pH of an endosome activates the M2 channel before
hemagglutinin-mediated fusion. Conductance of protons
acidifies the viral interior and thereby facilitates dissociation
of the matrix protein from the viral nucleoproteins— a re-
quired process for unpacking of the viral genome (1). M2
is a 97-residue single-pass membrane protein that has its
amino and carboxy termini directed toward the outside and
inside of the virion, respectively, and forms a homotetramer
in its native state (2). The four transmembrane helices yield
a channel in which His37 is the pH sensor and Trp41 is the
gate (3). M2 is the target of the anti-influenza drugs amanta-
dine and its methyl derivative rimantadine; recently, resis-
tance to these drugs has reached >90% (4).
The most complete structural information on the M2 trans-
membrane domain (M2TM) emerges from two studies pub-
lished simultaneously in 2008. Stouffer et al. (5) used x-ray
crystallography to determine the structure of residues 22–46
with and without amantadine in the detergent octyl-b-D-glu-
copyranoside. A crystal form that diffracts to 2.0 A˚ resolu-
tion was obtained at pH 7.3 in the absence of amantadine
from a peptide in which Ile33 was changed to selenomethio-
nine. The peptide crystallizes with six detergent molecules
that form a bilayer-like environment. The structure shows a
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0006-3495/09/11/2846/8 $2.00four-helix, cone-shaped bundle in which the helices are tilted
by ~35 with respect to the central axis. A second mutant,
Gly34Ala, was crystallized at pH 5.3 in the presence of aman-
tadine at 3.5 A˚ resolution. The two structures are very
similar, with the primary differences lying near the carboxy-
terminal region of the helices. Schnell and Chou (6) used
NMR to determine the structure of the rimantadine-bound
M2 peptide of residues 18–60 solubilized in dihexanoyl-
phosphatidylcholine (DHPC) micelles at pH 7.5. The
NMR results also show a four-helix bundle, but under the
conditions of the experiment the channel is substantially
less open than in the x-ray structure, and the tilt of each helix
with respect to the central axis is <23.
Despite the overall similarity of the channel structure, the
x-ray and NMR studies show major disagreement in the
position of the bound inhibitor (7). The x-ray structure shows
a single amantadine molecule in the middle of the channel,
surrounded by residues Val27, Ala30, Ser31, and Gly34. The
finding of electron density in the pore of the channel in the
presence of amantadine and the absence of density without
amantadine is consistent with the drug being present in the
pore of the channel, although at 3.5 A˚ resolution it cannot
be proven that the density represents amantadine. However,
the binding of amantadine at this position is supported by the
fact that mutations of Val27, Ala30, Ser31, and Gly34 were
observed in naturally occurring amantadine resistant strains
(8,9). In addition, the Hill coefficient for amantadine inhibi-
tion was shown to be ~1.0, consistent with a single amanta-
dine molecule binding to the tetramer (10,11). In contrast to
the x-ray structure, the NMR data show four rimantadine
molecules bound to the lipid-exposed outer surface of the
doi: 10.1016/j.bpj.2009.09.004
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end of the helices. The binding includes interactions with
residues 40–45, with a hydrogen bond between rimantadine
and Asp44 (7). Residues Leu40, Ile42, and Leu43 form the
hydrophobic walls of the binding pocket. Although the
NMR structure is well defined in the TM region, the four ri-
mantadine molecules display significant variability in their
interactions. Based on the NMR structure, Schnell and
Chou (6) proposed that the drug binds preferentially to,
and thereby stabilizes, the closed state. They note that aman-
tadine action is faster at neutral pH, where the channel is
mostly closed, than at low pH, where the open state is
favored (6), in accord with closed-state stabilization but
not with open-pore block (10,11). However, a recent func-
tional study (12) questions the significance of amantadine/ri-
mantadine binding outside of the channel pore. In particular,
using electrophysiological recordings in oocytes of Xenopus
laevis and in mammalian cells it was shown that mutations of
Asp44 and Arg45 to alanine do not alter the sensitivity of the
channel to the drug, suggesting that the interactions of riman-
tadine with Asp44 and Arg45 are not important for inhibition.
The goal of this study is to investigate the potential origin
of the different inhibitor binding modes in the two peptide-
detergent constructs used in the x-ray and the NMR studies.
Our main analysis tool is computational solvent mapping,
a technique developed for the identification and characteriza-
tion of ‘‘hot spots’’ in binding sites, i.e., regions of the protein
surface that are major contributors to the binding free energy
(13). Based on NMR (14) and x-ray (15) screening experi-
ments with fragment-sized compounds, such hot spots bind
a variety of small organic molecules, and hence the fraction
of such molecules binding to a particular site is a good pre-
dictor of its druggability (14). Computational mapping is an
analog of such screening experiments (16–18). The method
moves molecular probes—small organic molecules contain-
ing various functional groups—around the protein surface,
finds favorable positions using empirical free energy func-
tions, clusters the conformations, and ranks the clusters on
the basis of the average free energy (13,16–18). We have
developed mapping algorithms that reproduce very well the
results of the published NMR and x-ray screening studies
(18). Applications to a variety of proteins show that the probes
always cluster in major subsites of the binding site and the
amino acid residues that interact with the probes also bind
the specific ligands, suggesting that the number of different
probes at a consensus site correlates with the importance of
that site for ligand binding (13).
We have applied computational solvent mapping to both
x-ray and NMR structures of M2TM to identify the most
important binding sites. The mapping shows that both struc-
tures have binding hot spots both in the pore and on the lipid-
exposed outer surface of the channel, but the internal site
represents the main region of ‘‘druggability’’, i.e., the poten-
tially highest contribution to the binding free energy.
However, the NMR structure is based on a peptide/micelleconstruct that is able to accommodate the small molecular
probes used for the mapping, but appears to have a too
narrow pore to bind adamantine-sized molecules inside the
channel, and hence the drug can bind only at the exterior
sites. Our results also suggest that in the open state of the
channel the bound amantadine is more likely oriented with
its amino group toward the N-terminal end of the channel
rather than toward the C-terminal cytoplasmic end as shown
in the x-ray structure.
MATERIALS AND METHODS
The ligand-free x-ray structure (Protein Data Bank (PDB) code: 3bkd) and
rimantadine bound NMR structure (PDB: code 2rlf, model 1) of the M2
protein were mapped using the FTMAP algorithm consisting of four steps
as follows (18).
Step 1: soft rigid body docking of probe molecules
Protein structures are downloaded from the PDB (19). All bound ligands,
ions, and water molecules are removed. For each structure, we use 16 small
molecules as probes (ethanol, isopropanol, tert-butanol, acetone, acetalde-
hyde, dimethyl ether, cyclohexane, ethane, acetonitrile, urea, methylamine,
phenol, benzaldehyde, benzene, acetamide, and N, N-dimethylformamide).
For each probe, billions of docked conformations are sampled by soft rigid
body docking based on Fast Fourier Transform (FFT) correlation approach
(18). The method performs exhaustive evaluation of an energy function in
the discretized 6D space of mutual orientations of the protein (receptor)
and a small molecular probe (ligand). The center of mass of the receptor
is fixed at the origin of the coordinate system. The translational space is rep-
resented as a grid of 0.8 A˚ displacements of the ligand center of mass, and
the rotational space is sampled using 500 rotations. The energy expression
includes a stepwise approximation of the van der Waals energy with attrac-
tive and repulsive contributions, and an electrostatics/solvation term based
on Poisson-Boltzmann continuum calculation. The last term is approximated
as an interaction of probe charges with an electrostatic potential of the
protein-membrane system. This potential was calculated as a solution of a
linearized Poisson-Boltzmann equation, using the dielectric constants of
3¼ 4 and 3¼ 80 for the protein and the solvent, respectively. The membrane
was modeled as an infinite layer of low dielectric medium (3 ¼ 4), approx-
imately positioned with respect to the protein as shown in the original studies
(5,6). A salt concentration was 0.15 M in the solution phase on both sides of
the membrane. The potential was calculated by the Poisson-Boltzmann
module PBEQ of CHARMM (20) on a 0.4 A˚ spaced grid. Note that mapping
requires only the atomic coordinates of the two molecules, i.e., no a priori
information on the binding site is used. The 2000 best poses for each probe
are retained for further processing.
Step 2: minimization and rescoring
The 2000 complexes, generated in Step 1, are refined by off-grid energy
minimization during which the protein atoms are held fixed whereas the
atoms of the probe molecules are free to move. The energy function includes
the bonded and van der Waals terms of the polar hydrogen CHARMM force
field (20) and an electrostatic interaction term using the Poisson-Boltzmann
potential generated at Step 1. The values of the potential were smoothly
interpolated up to the first derivative from a 0.4 A˚ electrostatic grid using a
tricubic algorithm (21).
Step 3: clustering and ranking
The minimized probe conformations from Step 2 are grouped into clusters
using a simple greedy algorithm. The lowest energy structure is selected
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members of this cluster are removed, and the next lowest energy structure
is selected to start the second cluster. This step is repeated until the entire
set is exhausted. Clusters with <10 members are excluded from consider-
ation. The retained clusters are ranked on the basis of their Boltzman aver-
aged energies. Six clusters with the lowest average free energies are retained
for each probe.
Step 4: determination of consensus sites
To determine the hot spots, FTMAP finds consensus sites, i.e., regions on
the protein where clusters of different probes overlap (14–17). Therefore
the probe clusters are clustered again using the distance between the centers
of mass of the cluster centers as the distance measure and 4 A˚ as the clus-
tering radius. The consensus sites are ranked based on the number of their
clusters. Duplicate clusters of the same type are considered in the count.
Docking of amantadine and rimantadine uses Steps 1–3 of the FTMAP
algorithm, but all clusters (even with a single pose) are retained in Step 3.
RESULTS AND DISCUSSION
Analysis of the x-ray structure
We have mapped the unbound and amantadine-bound struc-
tures of the transmembrane domain (PDB codes 3bkd and
3c9j, respectively). Because the differences are small, we
report results for the higher resolution unbound structure.
The structures were downloaded from the Protein Data
Bank (19). All ligands, ions, and water molecules were
removed before mapping. For each probe, the six lowest
free energy clusters were superimposed (see Materials and
Methods) to identify the consensus sites (CS) defined by
overlapping probe clusters. The largest consensus site
(defined as CS1) binds 28 probe clusters that form a very
tight supercluster. Fig. 1 A shows the centers (i.e., the lowest
energy structures) of these 28 clusters that include four clus-
ters of isopropanol; three clusters of tert-butanol, phenol, and
benzaldehyde; two clusters of N,N-dimethylformamide,
acetone, and acetonitrile; and one cluster of each of the other
nine probe compounds. The figure also includes amantadine
(green), indicating that CS1 overlaps the amantadine binding
site. The probes in the 28 clusters of CS1 primarily interact
with the amino acid residues Ser31 (46.0%), Val27 (29.6%),
Ala30 (22.8%), and Gly34 (1.2%), where the numbers in
parentheses denote the percentage of nonbonded contacts
between all probes and the protein. It is well known that
each of these residues is mutated in some clinical isolates
of amantadine-resistant viruses (4,8,9). We also note that
in the lowest free energy clusters of most partially polar
probes (ethanol, isopropanol, tert-butanol, acetone, acetalde-
hyde, dimethyl ether, acetonitrile, methylamine, phenol,
benzaldehyde, acetamide, and N,N-dimethylformamide),
the polar moiety is oriented toward the amino end of the
channel, and forms a hydrogen bond with one of the Ser31
side chains. Indeed, the distributions of hydrogen bonds
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FIGURE 1 Analysis of the x-ray structure of the M2
channel (5). (A) Centers (i.e., lowest energy structures) of
the 28 probe clusters in the largest consensus site (CS1).
The color codes are as follows: oxygen, red; nitrogen,
blue, and carbon, cyan. The figure also shows the bound
amantadine with carbon atoms colored green, indicating
that CS1 overlaps the amantadine binding site. (B). Surface
representation of the channel with the four largest
consensus site. CS1, shown in A, and CS2, a supercluster
of 20 clusters between helices A and D, are hidden inside
the pore. Some probes are visible for CS3, a supercluster
of 17 probe clusters between helices B and C, shown in
magenta. CS4, shown in orange, includes only eight probe
clusters between helices C and D on the outside of the
channel, interacting with residues 43–45 that bind rimanta-
dine in the closed NMR structure. (C) Centers the lowest
and second lowest energy docked amantadine cluster,
shown in green and cyan, respectively. (D) The lowest
energy amantadine conformation is oriented toward the
N-terminal end of the channel, forming hydrogen bonds
with two Ser31 side chains on two adjacent helices.
Biophysical Journal 97(10) 2846–2853
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His37 0.1%. Thus, the region of highest hydrogen bonding
propensity is defined by the four Ser31 side chains, with
some of the probes extending slightly further toward the
extracellular end of the channel and interacting with the
carbonyl oxygen of the Val27 backbone. Fig. 1 A shows
that a number of the polar groups on the bound probes orient
downward into the direction of the cytoplasmic end of the
channel, but only ~5% of all hydrogen bonds occur with
the backbone of Ala30.
In addition to CS1 at the amantadine binding site, there are
three locations where relatively large numbers of probe clus-
ters overlap. CS2 with 20 probe clusters is located between
helices A and D, and CS3 with 17 clusters is between helices
B and C. Both CS2 and CS3 are elongated superclusters
located inside the pore, extending from Ile33 (changed to se-
lenomethionine in the x-ray structure) to the His37 side chain.
The existence of these favorable binding regions suggests
that the channel could accommodate more elongated mole-
cules than amantadine. Fig. 1 B shows the surface represen-
tation of the x-ray structure with the four largest consensus
sites. CS1 and CS2 are not visible inside the pore, and
only a few probes of CS3 show (in magenta) through the
openings between helices B and C. However, the figure
shows (in orange) that the eight probe clusters of the fourth
largest consensus site CS4 bind in a shallow pocket on the
lipid-exposed outer surface of the channel. What makes
CS4 interesting is that the probes interact with residues
43–45, i.e., the site that binds rimantadine in the NMR struc-
ture (6). Thus, the mapping shows a hot spot at this location
even for the x-ray structure. However, binding occurs only
between helices B and C, because the 35 tilt of helices
yields large openings rather than pockets on the other three
sides of the four-helix bundle. We also note (and will further
discuss) that binding at CS4 is partially due to the favorable
interactions between the probes and the interfacial region of
the bilayer used in our model.
To further test the relative importance of the hot spot
regions we have docked amantadine to the ligand-free
x-ray structure using the FFT algorithm. The advantage of
this approach is that there is no need for any a priori assump-
tion on the location of the binding site, and the entire protein
surface is considered in the docking calculation. Although
Step 1 of the algorithm is rigid body docking, the smooth
scoring function allows for partial atomic overlaps, and the
flexible minimization in Step 2 can account for the limited
flexibility of the amantadine molecule. Fig. 1 C shows the
centers (i.e., lowest energy conformations) in the two lowest
energy clusters. Cluster 1 (green) includes amantadine con-
formations with the NH2 group oriented upward, forming
hydrogen bonds with two Ser31 side chains on two adjacent
helices. In Cluster 2 (cyan) the NH2 group is oriented toward
the cytoplasmic end of the channel and hydrogen bonds to
the carbonyl group of Ala30. This second structure has better
overlap with the amantadine pose given in the x-ray struc-ture, but in the latter the orientation of the NH2 group could
not be determined due to the 3.5 A˚ resolution. We note that
docked amantadine molecules can also be observed at
consensus site CS4 on the lipid-exposed outer surface of
the channel, at the location that binds rimantadine in the
NMR structure. However, the average energy of this cluster
is much higher (13.43 kcal/mol) than the average energy of
Cluster 1 in the pore (23.72 kcal/mol).
Both mapping and docking results imply that amantadine
binding occurs in the pore at the CS1 site, in good agreement
with the x-ray structure (5). However, three observations
suggest that the amino group of amantadine may be preferen-
tially oriented toward the N-terminal extracellular end of the
channel rather than the C-terminus as deposited in the PDB.
First, the mapping results show much higher propensity for
hydrogen bonding in the region surrounded by the Ser31
side chains than anywhere else in the channel. Indeed, the
amino group of amantadine in Cluster 1 overlaps with polar
groups in the majority of partially polar probes, and forms
hydrogen bonds with the Ser31 side chains. As an example,
Fig. 1 D shows the lowest energy conformation of Cluster
1, with slightly higher energy members of the cluster interact-
ing with Ser31 side chains on the other helices. Second, the
average energy is somewhat lower in Cluster 1 than in
Cluster 2 (23.72 kcal/mol vs. 23.24 kcal/mol, respec-
tively). We note that these values do not include contribu-
tions from changes in rotational, translational, and vibrational
entropy, and hence do not represent valid estimates of the
binding free energy. Third, in our model the bulky adaman-
tane moiety is surrounded by small residues Ala30 and
Gly34, in agreement with the observation that Ala30Thr and
Gly34Glu result in resistance (22,23), and the amino group
of the drug is in the polar environment of the Ser31 side
chains. In contrast, in the x-ray structure the hydrophobic
adamantane cage is coordinated to the hydroxyls of Ser31,
making the model difficult to reconcile with the chemical
properties of the drug (24). The upward orientation of the
amantadine amino group is compatible with the observation
that the dipolar splitting and chemical shift of Val27 are unaf-
fected by inhibitor binding (25). A recent magic-angle-
spinning solid-state NMR study of M2TMP bound to lipid
bilayers also agrees with our model (26).
However, it is important to note that a number of models
and observations support the opposite orientation of amanta-
dine as seen in the deposited x-ray structure. An early model
of the M2 channel correctly predicted that the Val27 side
chains form the ‘‘lid’’ of the amantadine binding pocket
(27), but placed the drug with its NH2 group toward the cyto-
plasmic end, forming hydrogen bonds with the Ser31
hydroxyls. This model was further supported by neutron
diffraction data (28). Based on a more recent solid state
NMR structure of the channel (29), Yi et al. (30) carried
out a series of molecular dynamics (MD) simulations,
initially placing amantadine in the channel pore around
Ser31. According to the simulations the protein is quiteBiophysical Journal 97(10) 2846–2853
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the downward orientations, but the downward orientation
toward the cytoplasmic end occurs for the majority of the
time, with hydrogen bonds alternating among the Ser31
hydroxyls, the Ala30 backbone carbonyls, and water mole-
cules (30). Thus, although the preference for the upward
orientation seen in our rigid body docking removes the
apparent incompatibility of surface properties, the MD simu-
lations show that the drug molecule is quite mobile, and that
the downward orientation can be favorable if the presence of
water is taken into account explicitly. We recall that accord-
ing to our docking results the two orientations of amantadine
differ by <0.5 kcal/mol. In fact, the drug can turn over if
conditions change: the docking of amantadine to the Ser31
Ala mutant places the drug with its NH2 group downward,
hydrogen bonding to the backbone carbonyl of Ala30.
Because the mutant channel is known to be inhibited by
the drug, hydrogen bonds with the Ser31 side chains are
not required for inhibition.
Analysis of the NMR structure
The NMR structure of the closed channel shows rimantadine
molecules bound at four external sites on the lipid-facing
side of the channel, close to the membrane boundary. We
have mapped all 15 conformers included in the PDB file
2rlf, but show detailed results only for the first. As for the
open structure, all ligands were removed before mapping,
but in some of the figures we show the bound rimantadine
molecules for orientation. Interestingly, the largest con-
sensus site (defined as CS1 and shown in cyan in Fig. 2 A)
of 19 probe clusters is located close to the amantadine-
binding site seen in the x-ray structure. The probes in CS1
interact with residues Ala30 (56%), Ser31 (19.5%), Gly34
(16.2%), and Ile33 (7.8%). Although three of these residues
(Ala30, Ser31, and Gly34) are also part of the binding site in
the x-ray structure, the consensus site in the NMR structure
is slightly shifted toward the cytoplasmic end of the channel.
In addition, >99% of hydrogen bonds are formed with the
backbone carbonyl group of Ala30 rather than with the
Ser31 side chains as in the x-ray structure. In fact, the channel
is so narrow that even the smallest probes are unable to reach
the Val27 side chains. In addition to the primary hot spot in
the pore, Fig. 2 A shows the four rimantadine molecules
bound to the membrane exposed outer surface of the channel
as seen in the NMR structure (green).
Fig. 2 B shows again the prime consensus site CS1 in the
pore (cyan), and the next five largest (in terms of the number
of probe clusters) consensus sites. Site CS2 (yellow) includes
17 probe clusters between helices B and C, CS3 (magenta)
15 clusters between helices C and D, CS4 (orange) 13 clus-
ters between helices A and B, and CS5 (gray) 6 clusters
between helices A and D. The consensus sites CS2 through
CS5 are located at the four rimantadine binding sites, over-
lapping with the amino groups of the bound rimantadineBiophysical Journal 97(10) 2846–2853molecules in the NMR structure. The probes in these four
consensus sites interact with Asp44 (46.2%), Arg45 (25.3%),
Leu43 (13.0%), Leu46 (5.6%), and Ile42 (4.6%) that define the
rimantadine-binding pocket (6). Although the different sizes
of the external consensus sites suggest substantial asymme-
try of the channel, averaging the mapping results for the
15 structures shows that the four external sites are equally
important. Based on the numbers of probe clusters, the ex-
ternal sites (on the average with 16 probe clusters) are still
somewhat less important than the internal site with 19 probe
clusters. We emphasize that probe binding at the exterior
sites is largely due to the favorable interactions between
the partially polar probes and the interfacial region of the
lipid bilayer (31,32). In our model these sites are located
on the low dielectric side of the dielectric boundary, and
FIGURE 2 Analysis of the NMR structure of the M2 channel (6). (A) The
largest consensus site (CS1, shown in cyan) of 19 probe clusters, located
close to the amantadine-binding site seen in the x-ray structure. The four
rimantadine molecules in the NMR structure are shown in green. (B).
Consensus site CS1 in the pore (cyan), and consensus sites CS2 through
CS5 at the four external sites. (C) Same as in B using surface representation
of the M2 protein. (D) Centers of the six lowest energy amantadine clusters
docked to the NMR structure. Note the lack of amantadine binding at the
internal hot spot.
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as a uniform high dielectric medium. In fact, as shown in
Fig. 2 C using the surface representation of the protein, the
external sites are in broad and shallow pockets.
To test why rimantadine binding is seen only at the
external sites and not at the more important hot spot in the
pore we have docked the slightly smaller amantadine to
the NMR structure using the FFT approach used for the
mapping. As already mentioned, the advantage of this
approach is that a priori the entire protein surface, including
the interior of the channel, is available for binding, and no a
priori assumptions are made to constrain the search for the
putative binding site. The most important result is that the
docking does not place any drug molecule at the hot spot
within the pore, despite the dense sampling and allowing
for the rotation of the amantadine NH2 group. Fig. 2 D
shows the centers of the six lowest energy amantadine clus-
ters. The three lowest energy clusters, shown in green, cyan,
and magenta, overlap with bound rimantadine molecules. In
each cluster the NH2 group hydrogen bonds to the side chain
of Asp44. We note that these results are based on the analysis
of the first NMR conformer, and docking to the other 14
structures show comparable amantadine binding on all four
sides of the channel.
To further test whether the NMR methodology may have
missed inhibitor binding within the pore, in additional calcu-
lations we have placed amantadine molecules at the primary
hot spot in both orientations, and refined the structures using
energy minimization with a completely flexible ligand and
allowing for the flexibility of the protein side chains. Al-
though this procedure created a cavity that was able to
accommodate rimantadine, the ligand was shifted toward
the cytoplasmic side of the pore, and the docked rimantadine
did not interact with Ser31, Val27, or Ala30, confirming that
without allowing for changes in the backbone the pore in
the NMR structure is too narrow to provide access for a bulky
rimantadine-sized molecule, despite the existence of the
internal binding hot spot.
Although the docked amantadine positions are in good
agreement with the NMR results (6), the observed helical
tilt of 23 with respect to the lipid bilayer normal is way
out of the 32 to 38 range reported for the channel in the
open state (26,33–36). It is possible that the open and closed
states substantially differ, even in terms of the tilt angle. In
fact, a study using 1D and 2D IR spectroscopies indicates a
large conformational change at neutral pH when the channel
is closing (37). In addition, recent MD simulations at high
pH show the transmembrane helix to kink around Gly34
(38). The amantadine-bound form exhibits a single peak
~10 in the distribution of helix kink angle, but the apo
form exhibits two peaks ~ 0 and 40, and the corresponding
structures have narrow and wide pores, respectively (38).
Although the difference between x-ray and NMR struc-
tures of M2 may be due to the difference in pH, it is known
that detergent micelles may cause curvature stress tomembrane proteins affecting their structure (39,40), or
changing their functionality even when the structure is left
largely intact (41), and thus one has to consider this possi-
bility. In a relevant study, Poget and Girvin (41) determined
solution NMR structures of Staphylococcal multidrug resis-
tance transporter (Smr) in a number of detergents, including
lysopalmitoylphospatidylglycerol, dodecylphosphocholine,
n-dodecyl-b-D-maltopyranoside, and n-decyl-b-D-malto-
pyranosid. The Smr protein is known to be functional as a
dimer, with four transmembrane helices per monomer and
the chemical shift deviations were consistent with the pres-
ence of four individual a-helices in all four detergents. Poget
and Girvin (41) also carried out a functional assay by moni-
toring the binding of the drug tetraphenylphosphonium to
ascertain that Smr is in its native conformation. They found
reproducible ligand binding in n-dodecyl-b-D-maltopyrano-
side (and to a lesser extent in n-decyl-b-D-maltopyranosid),
but not in lysopalmitoylphospatidylglycerol or dodecylphos-
phocholine, indicating that although Smr formed a compact
dimeric a-helical bundle in these detergents, this conforma-
tion did not fully correspond to the protein’s native tertiary
structure.
The Smr example obviously does not imply that the M2
channel is substantially affected by the DHPC micelle, but
it shows that strong protein-micelle interactions are possible.
In particular, Chou et al. (39) noted that in the absence of the
peptide the DHPC micelle would adopt a spherical shape
with the diameter of 36 A˚, whereas the length of the M2
transmembrane channel is only ~30 A˚ (6). Due to the sym-
metry of the governing forces it is plausible to assume that
the channel extends straight through the middle of the
micelle, from one side to the other. Therefore the channel
appears to be stretched, and this may be responsible for the
tilt angle that is substantially smaller than the one reported
for the M2 channel in other biological membranes (33–36).
However, little information is available on micelle structure
in the presence of a protein. For example, Fernandez et al.
(42) studied the interactions between DHPC and the integral
membrane protein OmpX with a transmembrane height of
28 A˚, thus similar to the M2 channel. They assumed that
the DHPC molecules are oriented perpendicular to the
hydrophobic protein surface as a distorted monolayer, with
the polar headgroups forming the surface of a prolate ellip-
soid. Thus, the environment of the protein substantially
differs from the conditions seen in a natural lipid bilayer.
CONCLUSIONS
Computational solvent mapping of both x-ray and NMR
structures of the influenza M2 proton channel shows the
most important binding hot spot inside the pore, surrounded
by the amino acid residues Ala30, Ser31, and Gly34. In the
x-ray structure some probes also interact with the Val27
side chains, and most hydrogen bonds are formed with the
Ser31 hydroxyls. In the much narrower pore of the NMRBiophysical Journal 97(10) 2846–2853
2852 Chuang et al.structure the probes cluster ~2 A˚ closer to the cytoplasmic
end of the channel, and do not interact with the Val27 side
chains. In addition, the polar groups form hydrogen bonds
with the backbone amino group of Ala30 rather than with
the Ser31 side chains. In both x-ray and NMR structures,
the mapping shows additional hot spots on the lipid exposed
exterior of the channel at the location that is seen to bind
rimantadine in the NMR structure. However, these hot spots
are weaker (include fewer probe clusters) than the one in the
pore, and are largely determined by polarization effects in the
interfacial region of the lipid bilayer.
Docking of amantadine to the two structures confirms our
mapping results and agrees well with experimental data. In
the x-ray structure the docked poses of amantadine form
low energy clusters only at the main hot spot in the pore.
Combining the results of mapping and docking calculations
suggest that the amino group of amantadine is oriented
toward the N-terminal end of the channel, and forms
hydrogen bonds with the Ser31 hydroxyls, whereas the ada-
mantine ring primarily interacts with the Ala30 and Gly34.
However, the energy difference between N-terminal and
C-terminal orientations is small, and a number of arguments
suggest that the bound drug is highly mobile, with both
orientations feasible. In contrast to the x-ray structure, dock-
ing of amantadine to the NMR structure fails to place any
inhibitor molecules inside the pore, suggesting that the
M2 peptides in dihexanoyl-phosphatidyl-choline detergent
micelles form a channel that is too narrow to provide access
to the internal site for the bulky adamantane moiety. Thus,
the drugs can bind only at the lipid-exposed external sites
despite the hot spot in the middle of the channel. Although
the narrow pore may be induced by high pH, the conditions
in the DHPC micelle substantially differ from those seen in a
natural lipid environment, and this also may affect the shape
of the channel.
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